
Autoimmune Neurologist @mayoclinicneuro | Opinions are my own.
Rochester, MN
Joined September 2020
- Tweets88
- Following138
- Followers105
- Likes244
Smathorn Thakolwiboon retweeted
Excellent review by @SaraMariottoMD & colleagues from #MEDEN group on fluid biomarkers in #MOGAD & #NMOSD
➡️ Particularly nice figure on live vs fixed CBA summarizing data to date for both diseases👇
neurology.org/doi/10.1212/NX…
Smathorn Thakolwiboon retweeted
Lots of abbreviations in the #MOGAD world!
MOG
CCE
ON
TM
EPD
@EoinFlanagan14 teaching #Sendai 2026 neuroimmunology meeting about #MOGAD
@TheMOGProject @TheSumairaFDN
@MayoClinicNeuro @MayoClinic
Smathorn Thakolwiboon retweeted
Happy to share @NisaVorasoot et al study of demographics & seasonality of 10K MOG & AQP4 IgG (+) showing females predominate in #MOGAD (1.5:1) and #NMOSD (6.2:1) & a pediatric predilection of #MOGAD with onset & attacks of both slightly higher in winter👇neurology.org/doi/10.1212/WN…
Smathorn Thakolwiboon retweeted
Happy to share @moritz_nieder et al study of psychiatric comorbidities in #MOGAD ➡️ Screen for depression, anxiety & ADHD in #MOGAD ➡️ Psych disorders peak at #MOGAD onset but often precede #MS diagnosis by 5-10 yrs aligning with its pre-symptomatic phase👇jnnp.bmj.com/content/early/2…
Smathorn Thakolwiboon retweeted
The Mayo MS and Autoimmune fellows, alumni, and consultants came together for an incredible time of connection and collaboration. Grateful for the camaraderie, mentorship, and shared passion for advancing neurology! 💙 #NeuroTwitter #MS #Autoimmune #mayoneurofellowships
Smathorn Thakolwiboon retweeted
Such an honor to be hosted by Vyanka and Lara on the @immunotea podcast ➡️ A perfect setting to review the diagnosis and treatment of #AutoimmuneEncephalitis 👇 podcasts.apple.com/us/podcas…
Smathorn Thakolwiboon retweeted
This is a great point, the rate of lesion resolution is dependent on the timing of repeat imaging with a median time to resolution of 3 months and approx. 90% of lesion resolution occurring within the first year 👇 neurology.org/doi/10.1212/WN…
🎙️ Our podcast episode out now!
We discuss Plasma Exchange and therapeutics in MOGAD.
Huge thanks to Dr. Chen and @EoinFlanagan14 for incredible mentorship, and to our global collaborators who made this possible! 🌍 #MOGAD #AutoimmuneNeurology #Neuroimmunology #Neurology
This quoted post is unavailable.
Smathorn Thakolwiboon retweeted
Excited to share our new study in Journal of Neurology! 🇪🇸🇬🇧
A multicenter effort between Spain & UK. We explored anti-CGRP + immunomodulatory tx in #migraine
🔗 doi.org/10.1007/s00415-025-1…
#CGRP #Neuroimmunology #Headache #Research
Smathorn Thakolwiboon retweeted
If you haven't already, mark your calendars! We're so excited to host the U.S. #MOGAD Patient Summit on Saturday, August 16th in collaboration with Mayo Clinic.
Plan on learning the latest information on this disease, its diagnosis, management & treatment from the clinicians and researchers at the front lines as well as updates on their research in one of the most important clinics in the US & the world for treating & researching MOGAD.
You can join in person at Mayo Clinic in Rochester, Minnesota or virtually via livestream. Details and registration coming soon, so don't miss out!
@UCBMedia, @Roche, @EoinFlanagan14, @chenmayo, @MayoClinicNeuro
Smathorn Thakolwiboon retweeted
Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice | Neurology neurology.org/doi/10.1212/WN…
Well done @PietroZara6 & @PaolaChessa4 🤝
Smathorn Thakolwiboon retweeted
#CASPR2-#antibody diseases are provide clues to mechanisms of autoantigen-specific tolerance
Here - in @ScienceAdvances - we show how central and peripheral B cell tolerance licences pathogenic CASPR2 antibody generation.
science.org/doi/10.1126/scia…
More below 👇🏿
Smathorn Thakolwiboon retweeted
🗞️📰 We at TSF have some BIG news to share…
pcori.org/research-results/2…
Smathorn Thakolwiboon retweeted
Autoimmune encephalitis: recovery, residual symptoms and predictors of long-term sequelae
jnnp.bmj.com/content/early/2… @smathorn
Smathorn Thakolwiboon retweeted
Low antibodies (hypogammaglobulinemia) in people with MS, often a side effect of medication. An expert commentary (senior author Prof. Gavin Giovanoni) discussing risk of infection, response to vaccination, holding medicine, and IVIG. msard-journal.com/article/S2…
Excited to share our latest work on autoimmune encephalitis outcomes, now published in JNNP! Grateful to Dr. Andrew McKeon for his incredible mentorship throughout this project. #AutoimmuneNeurology #AutoimmuneEncephalitis #PatientOutcomes
Autoimmune encephalitis: recovery, residual symptoms and predictors of long-term sequelae
jnnp.bmj.com/content/early/2… @smathorn
Smathorn Thakolwiboon retweeted
Study observed raised opening pressure in 25% of MOGAD attacks in adults and children and identified its association with leptomeningeal and cerebral involvement and potentially greater attack severity in non–optic neuritis.
ja.ma/4decXPn
It has been an incredible experience working with such talented and passionate colleagues over the past two years. Don’t miss this opportunity to join a fantastic team! 🧠👏"
Smathorn Thakolwiboon retweeted
Progression independent of relapse activity (PIRA) accounts for most events causing disability accumulation in #MultipleSclerosis.
A meta-analysis in the real-world context from @SanCamilloIRCCS ▶️ journals.sagepub.com/doi/abs…
























